Is sermorelin from a compounding pharmacy legally the same as a research chemical?
Not by this site's national fields. Sermorelin's US legal line reads prior approval discontinued, available via compounding pharmacies. That is the leftover of Geref, which was taken off the market. The UK, Australia, and Canada lines are not currently licensed or not approved. A research-chemical seller that labels sermorelin research use only is not the compounding route that field describes. This dataset does not name pharmacies, does not track which states allow that compounding, and does not turn an old, dropped approval into a current FDA approval.
Studies in people from the compound pages this answer belongs to
- Sermorelin
- Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men 1992 PMID 1379256
- Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group 1996 PMID 8772599
- Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women 1997 PMID 9141536
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of names, absences, and legal limits. Brand versus molecule, side effects this site's citations did not measure, how long the trials actually ran, what national legal-status fields can say, and why two-compound answers do not scale to a larger stack.